SCHEMBL6604726

SCHEMBL6604726

CCOC(=O)c1nc2cc(CN(C)C)c([N+](=O)[O-])cc2nc1OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.38
MITF O75030 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 2/20 0.38
GALR2 O43603 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HPGD P15428 1/20 0.38
XBP1 P17861 1/20 0.38
CCR6 P51684 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GLP1R P43220 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 4/20 0.35
RAB9A P51151 2/20 0.35
PTGER4 P35408 1/20 0.35
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6607045 0.84 ALDH1A1 (0.43) ALDH1A1MITFSMN1; SMN2LMNAPOLB
SCHEMBL6602596 0.82 ALDH1A1 (0.41) ALDH1A1MITFSMN1; SMN2LMNAPOLB
SCHEMBL6602007 0.79 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2LMNAPTGS1PTGS2
SCHEMBL8369082 0.78 PPARG (0.43) ALDH1A1MITFSMN1; SMN2LMNAPOLB
SCHEMBL6604555 0.76 ALDH1A1 (0.44) ALDH1A1MITFSMN1; SMN2LMNAPOLB
SCHEMBL6607136 0.76 ALDH1A1 (0.43) ALDH1A1MITFSMN1; SMN2LMNAPOLB
SCHEMBL6376052 0.75 ALDH1A1 (0.45) ALDH1A1MITFSMN1; SMN2LMNAPOLB
SCHEMBL6603316 0.75 ALDH1A1 (0.45) ALDH1A1MITFSMN1; SMN2LMNAPOLB
SCHEMBL6607856 0.75 MAPT (0.45) ALDH1A1MITFSMN1; SMN2MAPT
SCHEMBL6380676 0.73 ALDH1A1 (0.44) ALDH1A1MITFSMN1; SMN2LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1020453-B1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERIVATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-05-19 EP disclosed
US-6348461-B1 CENTRAL NERVOUS SYSTEM ANTAGONIST WITH HETEROCYCLIC SUBSTITUENTS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1020453-A1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERI VATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed